Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
Journal
Oral Oncology
Journal Volume
128
Date Issued
2022
Author(s)
Rischin D.
Harrington K.J.
Greil R.
Soulières D.
Tahara M.
de Castro Jr G.
Psyrri A.
Braña I.
Neupane P.
Bratland Å.
Fuereder T.
Hughes B.G.M.
Mesía R.
Ngamphaiboon N.
Rordorf T.
Ishak W.Z.W.
Mendoza R.G.
Jia L.
Chirovsky D.
Norquist J.
Jin F.
Burtness B.
SDGs
Publisher
Elsevier Ltd
Type
journal article
